Merck’s Idvynso, a new, two-drug single-tablet regimen of 100 mg doravirine and 0.25 mg islatravir gets US FDA approval for the treatment of HIV-1 infection: Rahway, New Jersey ...
This approval marks an important new chapter in Merck’s long-standing commitment to research and discovery for people living ...
An expert from CN Bio explores considerations when choosing an in vitro liver model . As the major drug metabolising organ, ...
Researchers at Kent have established a computational protocol that could accelerate the development of more effective ...
April 7 (Reuters) - Insmed (INSM.O), opens new tab said on Tuesday it would discontinue the development of its treatment for a chronic, inflammatory skin condition, after the drug failed a mid-stage ...
Serious fungal infections are on the rise, and many hospital-acquired cases are becoming harder to treat as fungi become ...
A study of more than 11,000 teens finds cannabis use tied to slower gains in memory, focus and thinking speed as well as ...
A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing ...
Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting ...
A UCLA-led international research collaboration has unveiled a new technology that may help scientists better understand how ...
There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...
Sanford, Fla. — A plan to build more than 200 apartments in the environmentally sensitive Wekiva Study Area is at a standstill. This comes after Seminole County planning officials said the project is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results